JMAR inks deals augmenting BioSentry core technology
Company extends purchase agreement with The LXT Group and, with separate agreements with PointSource Technologies and NASA, consolidates microorganism detection technology for BioSentry product line...
SAN DIEGO, Jan. 13, 2005 (BUSINESS WIRE) -- JMAR Technologies Inc. has extended the closing of its agreement to purchase assets of The LXT Group and has finalized two license agreements that collectively serve to secure and enhance the available microorganism monitoring technology and equipment for BioSentryTM, a real-time, online system for monitoring water supplies.
JMAR has deferred the closing of its previously announced purchase agreement with The LXT Group as the parties discuss certain modifications to that agreement. The purchase agreement provides for the purchase of LXT's assets, including all intellectual property (IP) rights related to LXT's prior development of the BioSentry product. Greg Quist and David Drake of LXT teamed with JMAR during the past nine months to develop the BioSentry and were also key contributors to development of microorganism detection systems at PointSource Technologies (PST).
JMAR and PointSource have agreed to consolidate the pioneering work of PST with the recent advances from the JMAR/LXT team to create a comprehensive knowledge base in the field of waterborne microorganism classification and detection. This agreement grants JMAR an exclusive license to all PST IP and transfers to JMAR all PST equipment, test data, and microorganism detection system prototypes. The PST microorganism detection systems were beta tested in 2002 and 2003: one was used to monitor water security at the Super Bowl; the other was operated at a Southern California water utility for 18 months.
Additionally, JMAR has entered into a License Agreement with the National Aeronautics and Space Administration (NASA) awarding JMAR an exclusive worldwide license to U.S. Patent No. 6,313,908 ("Apparatus and Method Using a Holographic Optical Element for Converting a Spectral Distribution to Image Points"), for applications related to the detection and identification of light-scattering media in liquids.
"JMAR is pleased to have collected an important body of IP from NASA and from PointSource Technologies. The operational experience and IP developed by PointSource adds significantly to JMAR's body of knowledge as we continue testing our own beta models," said Ronald A. Walrod, CEO of JMAR. "The aggregation of this IP will also further protect our competitive position as we move toward commercialization of the BioSentry product line. Additionally, the NASA and PointSource technology increases the BioSentry design options available to JMAR."
JMAR is currently testing and evaluating BioSentry beta units and assembling the marketing, production, system installation, and customer support teams needed for product launch. The Company is also actively negotiating agreements for beta installations with customers in key markets including homeland security, water utilities, and beverage production.
San Diego-based JMAR Technologies Inc. (www.jmar.com) is a leading innovator in the development of laser-based equipment for imaging, analysis and fabrication at the nano-scale. The Company is leveraging over a decade of laser and photonics research to develop a diverse portfolio of products with commercial applications in rapidly growing industries, while continuing to provide support for the U.S. Government's Defense Microelectronics Activity (DMEA) semiconductor fabrication facility. JMAR is targeting the nanotech, bioscience and semiconductor industries with its BritelightTM laser; Compact X-ray Light Source; X-ray Microscope - for 3D visualization of single cells and polymers - and its X-ray Nano Probe, enabling interaction, analysis and modification at the nano-scale. JMAR also maintains strategic alliances for the development of BioSentry and READ - biological and chemical sensors for homeland security, environmental and utility infrastructure industries.